Authored by Chris Schroeder
Although Yaz and Yasmin rank among the most popular birth control pills in the world, recent studies show that the progestin hormone drospirenone used in both meds can greatly increase patients’ risks of blood clots.
Already, thousands of women affected by blood clot conditions like pulmonary embolism, deep vein thrombosis (DVT) or stroke have filed lawsuits against Bayer and been compensated for their injuries.
Now, the latest report from the German drug maker shows they have paid more than $1.5 billion to women with Yaz blood clots, and will continue these settlements into 2014.
Lawyers are urging anyone who suffered a blood clot while taking Yaz or Yasmin to learn about their options before it is too late. Even those who experienced injuries years ago may be eligible for a Yaz settlement in 2014.
Yasmin and Yaz were introduced to the United States market in 2001 and 2006. So far, the FDA has received more than 20,000 reports of women suffering severe blood clot side effects of Yaz or Yasmin. However, the agency has decided not to issue a Yaz recall.
According to lawyers, many of those who suffered injury prior to labeling changes in mid-2012 will be eligible for a Yaz lawsuit and settlement. This includes patients that took either the brand name or generic versions.
In Bayer’s last financial report, they admitted they have so far settled around 6,800 Yaz lawsuits for blood clot injuries like DVT and pulmonary embolism. They also stated they will continue to evaluate cases for settlement into 2014.
If you suffered a pulmonary embolism, DVT or stroke, it is important to speak with an attorney for Yaz claims. It costs nothing to learn if you qualify and there are no attorney’s fees unless you receive compensation.
Due to the specialized nature of these cases, DrugRisk only recommends lawyers who have already settled hundreds of Yaz lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Yaz or Yasmin, or to speak with a lawyer.